Integrity Alliance LLC. Purchases Shares of 2,845 The Clorox Company $CLX

Integrity Alliance LLC. purchased a new stake in The Clorox Company (NYSE:CLX) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,845 shares of the company’s stock, valued at approximately $419,000.

Other large investors also recently bought and sold shares of the company. Wood Tarver Financial Group LLC acquired a new position in Clorox in the fourth quarter valued at approximately $31,000. Ransom Advisory Ltd acquired a new position in shares of Clorox during the 1st quarter worth approximately $35,000. GW&K Investment Management LLC raised its stake in shares of Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares during the period. Roble Belko & Company Inc raised its stake in shares of Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock worth $53,000 after buying an additional 211 shares during the period. Finally, Menard Financial Group LLC acquired a new position in shares of Clorox during the 4th quarter worth approximately $63,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 0.5%

NYSE CLX opened at $123.75 on Friday. The business has a fifty day moving average price of $124.27 and a 200 day moving average price of $132.44. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $15.14 billion, a P/E ratio of 18.98, a P/E/G ratio of 1.00 and a beta of 0.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the prior year, the company earned $1.82 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were paid a $1.24 dividend. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 annualized dividend and a yield of 4.0%. This is an increase from Clorox’s previous quarterly dividend of $1.22. Clorox’s dividend payout ratio is currently 76.07%.

Analyst Ratings Changes

CLX has been the subject of several research analyst reports. Citigroup reaffirmed a “neutral” rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. JPMorgan Chase & Co. upped their target price on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a research note on Monday, September 8th. UBS Group reduced their target price on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research note on Thursday, July 17th. Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. Finally, Morgan Stanley reduced their target price on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus target price of $142.18.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.